Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Research and development | 18M | 13M |
| Selling, general and administrative | 9M | 7M |
| Operating income | −28M | −20M |
| Net income | −26M | −19M |
| Earnings per share | −1.32 | −1.11 |
| Earnings per share, diluted | −1.32 | −1.11 |
| Weighted average shares | 22M | 17M |
| Weighted average shares, diluted | 22M | 17M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 25M | 32M | 35M | 27M | 30M | 19M | 17M | 18M |
| Current assets | 25M | 32M | 36M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −16M | −12M |
| Share-based compensation | 6M | 5M |
| Investing cash flow | — | 0 |
| Financing cash flow | 29M | 12M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 27M |
| 30M |
| 19M |
| 17M |
| 18M |
| Total assets | 25M | 32M | 36M | 27M | 30M | 19M | 17M | 18M |
| Current liabilities | 11M | 13M | 12M | 10M | 9M | 9M | 6M | 6M |
| Total liabilities | 11M | 13M | 12M | 10M | 9M | 9M | 6M | 6M |
| Equity | 14M | 18M | 24M | 17M | 21M | 10M | 11M | 13M |
| Shares outstanding | 27M | 26M | 26M | 24M | 24M | 19M | 19M | 19M |
| Shares issued | 27M | 26M | 26M | 24M | 24M | 19M | 19M | 19M |